These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38035173)

  • 1. Evaluation of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Questionnaire and its Relations to Cannabis-Related Problems.
    Gette JA; Littlefield AK; Victor SE; Schmidt AT; Garos S
    Cannabis; 2023; 6(3):64-86. PubMed ID: 38035173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring cannabis consumption: Psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU).
    Cuttler C; Spradlin A
    PLoS One; 2017; 12(5):e0178194. PubMed ID: 28552942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantity and frequency of cannabis use in relation to cannabis-use disorder and cannabis-related problems.
    Callaghan RC; Sanches M; Kish SJ
    Drug Alcohol Depend; 2020 Dec; 217():108271. PubMed ID: 32977043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive validity of cannabis consumption measures: Results from a national longitudinal study.
    Buu A; Hu YH; Pampati S; Arterberry BJ; Lin HC
    Addict Behav; 2017 Oct; 73():36-40. PubMed ID: 28463803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults.
    Leadbeater BJ; Ames ME; Linden-Carmichael AN
    Addiction; 2019 Feb; 114(2):278-293. PubMed ID: 30276906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.
    Padwa H; Huang D; Mooney L; Grella CE; Urada D; Bell DS; Bass B; Boustead AE
    Subst Abuse Treat Prev Policy; 2022 May; 17(1):36. PubMed ID: 35527269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing Cannabis Use in Young Adults With Psychosis Using iCanChange, a Mobile Health App: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC).
    Tatar O; Abdel-Baki A; Wittevrongel A; Lecomte T; Copeland J; Lachance-Touchette P; Coronado-Montoya S; Côté J; Crockford D; Dubreucq S; L'Heureux S; Ouellet-Plamondon C; Roy MA; Tibbo PG; Villeneuve M; Jutras-Aswad D
    JMIR Res Protoc; 2022 Nov; 11(11):e40817. PubMed ID: 36427227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Pain, Cannabis Legalization and Cannabis Use Disorder in Veterans Health Administration Patients, 2005 to 2019.
    Hasin DS; Wall MM; Alschuler D; Mannes ZL; Malte C; Olfson M; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Fink DS; Livne O; McDowell Y; Sherman S; Saxon AJ
    medRxiv; 2023 Jul; ():. PubMed ID: 37503049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risky decision-making as an antecedent or consequence of adolescent cannabis use: findings from a 2-year longitudinal study.
    Pacheco-Colón I; Lopez-Quintero C; Coxe S; Limia JM; Pulido W; Granja K; Paula DC; Gonzalez I; Ross JM; Duperrouzel JC; Hawes SW; Gonzalez R
    Addiction; 2022 Feb; 117(2):392-410. PubMed ID: 34184776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents.
    Wittchen HU; Fröhlich C; Behrendt S; Günther A; Rehm J; Zimmermann P; Lieb R; Perkonigg A
    Drug Alcohol Depend; 2007 Apr; 88 Suppl 1():S60-70. PubMed ID: 17257779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.
    Tomko RL; Baker NL; Hood CO; Gilmore AK; McClure EA; Squeglia LM; McRae-Clark AL; Sonne SC; Gray KM
    Psychopharmacology (Berl); 2020 Feb; 237(2):479-490. PubMed ID: 31712969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis users demonstrate enhanced neural reactivity to reward: An event-related potential and time-frequency EEG study.
    Crane NA; Funkhouser CJ; Burkhouse KL; Klumpp H; Phan KL; Shankman SA
    Addict Behav; 2021 Feb; 113():106669. PubMed ID: 33035810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal associations between impulsivity and alcohol and cannabis use frequency, quantity, and problems among military veterans.
    Kearns NT; Gunn RL; Stevens AK; Berey BL; Metrik J
    Psychol Addict Behav; 2022 Nov; 36(7):762-774. PubMed ID: 35238593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial interventions for cannabis use disorder.
    Gates PJ; Sabioni P; Copeland J; Le Foll B; Gowing L
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD005336. PubMed ID: 27149547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States.
    Wu LT; Zhu H; Mannelli P; Swartz MS
    Drug Alcohol Depend; 2017 Aug; 177():153-162. PubMed ID: 28599214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda.
    Loflin MJE; Kiluk BD; Huestis MA; Aklin WM; Budney AJ; Carroll KM; D'Souza DC; Dworkin RH; Gray KM; Hasin DS; Lee DC; Le Foll B; Levin FR; Lile JA; Mason BJ; McRae-Clark AL; Montoya I; Peters EN; Ramey T; Turk DC; Vandrey R; Weiss RD; Strain EC
    Drug Alcohol Depend; 2020 Jul; 212():107993. PubMed ID: 32360455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints.
    Borodovsky JT; Sofis MJ; Sherman BJ; Gray KM; Budney AJ
    Psychol Addict Behav; 2022 Aug; 36(5):515-525. PubMed ID: 35084903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends and correlates of cocaine use and cocaine use disorder in the United States from 2011 to 2015.
    John WS; Wu LT
    Drug Alcohol Depend; 2017 Nov; 180():376-384. PubMed ID: 28961544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise, Decision-Making, and Cannabis-Related Outcomes among Adolescents.
    Pacheco-Colón I; Salamanca MJ; Coxe S; Hawes SW; Gonzalez R
    Subst Use Misuse; 2021; 56(7):1035-1044. PubMed ID: 33829950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting maladaptive reactivity to negative affect in emerging adults with cannabis use disorder: A preliminary test and proof of concept.
    Wolitzky-Taylor K; Glasner S; Tanner A; Ghahremani DG; London ED
    Behav Res Ther; 2022 Mar; 150():104032. PubMed ID: 35032700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.